Scalp cooling to prevent hair loss with new antibody-drug conjugates
Part of Skin clinical trials.
This study tests whether a cooling cap can prevent hair loss in women receiving specific antibody-drug conjugates (trastuzumab-deruxtecan, sacituzumab-govitecan, or datopotamab-deruxtecan) for advanced solid tumors. If it works, you may keep more of your hair during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have advanced or metastatic solid tumor and are about to start one of three specific antibody-drug conjugates
- You have enough visible scalp hair without significant thinning or hair loss
- You can walk and care for yourself (ECOG score 0, 1, or 2)
- You do not have certain conditions like cold intolerance, scalp skin disease, or uncontrolled migraines made worse by cold
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This trial tests whether cooling the scalp during chemotherapy can help reduce chemotherapy-related hair loss. It focuses on people with curly or kinky hair who are having certain cancer treatments, and it checks safety and how much hair loss happens.
This study tests if a cooling cap can help reduce hair loss during chemotherapy for breast cancer. Hair loss can be distressing, and this trial aims to see if the cap helps you keep more hair while still getting the treatment you need.
This study looks at whether “cold cap” scalp cooling can help prevent or reduce hair loss in children getting chemotherapy. It’s aimed at kids treated with certain chemotherapy medicines and who may be at risk for losing their hair.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.